Price Band
₹135 - ₹142
Lot Size
1000
Issue Size
₹69.47 Cr
GMP
N/A
Subscription
5.67x
Analyzing...
IPO Schedule
1
Open
8 Aug 2025
2
Close
12 Aug 2025
3
Allotment
-
4
Listing
18 Aug 2025
About Star Imaging & Path Lab
Star Imaging & Path Lab is an integrated diagnostic service provider with a network of labs and collection centers. They offer a range of pathology and radiology services, catering to individual patients and healthcare institutions.
Key Strengths
- High Return on Equity (ROE) of 40.65% indicates efficient profitability.
- Attractive Price to Earnings (P/E) ratio of 12.01 suggests potential undervaluation compared to industry peers.
- Established network of labs and collection centers provides a strong foundation for future growth.
- Integrated diagnostic service offering allows for comprehensive patient care and revenue diversification.
- SME segment listing may attract higher investor interest due to the potential for rapid growth.
Risk Factors
- •Competition from established players in the diagnostic services industry.
- •Dependence on maintaining accreditations and regulatory compliance.
- •Potential fluctuations in reagent costs and equipment maintenance expenses.
Valuation Analysis
The IPO appears reasonably priced considering the company's high ROE and relatively low P/E ratio; however, investors should carefully assess the risks associated with the SME segment and competitive landscape.
IPO Details
ExchangeBSE
SegmentSME
ISININE0YG001013
Face Value₹10
Lot Size1000
Issue Size₹69.47 Cr
Key Metrics
ROE40.65%
ROCE29.92%
P/E Ratio12.01
Industry P/E20
EPS11.82
PAT Margin19.10%
Debt/Equity0.69
Growth & Quality
ProfitableYes ✓
Subscription
Total0.05x
Imbalance Ratio101.0x
Documents
RHP not available
Key Dates
Open Date8 Aug 2025
Close Date12 Aug 2025
Listing18 Aug 2025